Biblio
A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation. Br J Pharmacol. 2021.
Towards a Gold Standard Functional Readout to Characterize In Vitro Lung Barriers. Eur J Pharm Sci. 2022:106305.
.